Investigational melatonin receptor agonists. - Wikidata - wikimedia - TriplyDB

Investigational melatonin receptor agonists.

Investigational melatonin receptor agonists.

http://www.wikidata.org/entity/Q37735169

about

Fragile X syndrome and targeted treatment trials.Urinary excretion of melatonin and association with breast cancer: meta-analysis and review of the literature Melatonergic drugs in development.Melatonin in aging and disease -multiple consequences of reduced secretion, options and limits of treatment.Chronobiology of Melatonin beyond the Feedback to the Suprachiasmatic Nucleus-Consequences to Melatonin Dysfunction.Melatonin and pancreatic islets: interrelationships between melatonin, insulin and glucagon A molecular and chemical perspective in defining melatonin receptor subtype selectivity.Antinociceptive effects of novel melatonin receptor agonists in mouse models of abdominal pain.Recent advances in the development of melatonin MT(1) and MT(2) receptor agonists.Tasimelteon for insomnia.Drug-induced sleep: theoretical and practical considerations.Melatonin, the circadian multioscillator system and health: the need for detailed analyses of peripheral melatonin signaling.Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.Cardiovascular effects of melatonin receptor agonists.Melatonin in cardiovascular disease.Neurobiology, pathophysiology, and treatment of melatonin deficiency and dysfunction

P2860

Q26865162-5C973B7C-07E5-42D0-864E-3C319ED28465 Q34042761-70DCC9EA-778C-454F-A53E-E0EFB235BC78 Q34440574-C56177E8-97ED-498E-AEF9-642F29D30449 Q36040915-C86A2042-5A44-4A97-B36F-9BE2CE740A83 Q36790442-6440AA72-7C5C-4107-914F-D91E84D19AA4 Q36820392-F68F4C39-CB42-490F-A9C0-8C29FE7491C0 Q37225147-2AB13AB5-C194-4FDF-AB18-837B03ED7996 Q37578651-3BC34238-241C-4C0C-8693-EBA609109671 Q37763715-E2CB864A-6AF6-4CEA-8026-074268C7DB90 Q37872781-61BEA17C-5E5E-4145-954B-B2255EE06022 Q37939671-9C07C007-62BC-4343-A273-20F5EA75E489 Q37950409-8740B2EE-503C-4D30-A6BE-D2D0FF976DA3 Q38022179-13FDA30E-29D6-457F-AA80-F5B157515BB7 Q38037124-4982AC68-AB70-4A3B-83B8-27B4E5F7CB69 Q45998083-C30BDA24-0F29-425D-9A0D-F4084114D649 Q58914961-CB714588-77F7-4883-8F26-63C5C3520FD9

P2860

Investigational melatonin receptor agonists.

http://www.wikidata.org/entity/Q37735169

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Investigational melatonin receptor agonists.

@en

Investigational melatonin receptor agonists.

@nl

type

label

Investigational melatonin receptor agonists.

@en

Investigational melatonin receptor agonists.

@nl

prefLabel

Investigational melatonin receptor agonists.

@en

Investigational melatonin receptor agonists.

@nl

P1433

Q37735169-F37A649A-9056-4C04-A6C6-F5FFFB345BDB

P1476

Q37735169-3E6D9791-2A4D-46FA-A464-8CB21A23C160

P2093

Q37735169-D8540913-AEE5-4452-A434-8DA2A02D58C7

P2860

Q37735169-0E9611B3-EB7E-4D67-8DF8-40B9C64681B5

Q37735169-0F33ED42-DE6F-47BC-A740-8FBA537C91A4

Q37735169-13001EB4-7557-4177-BDDC-B523A60E089A

Q37735169-165ADD1B-A5AA-4D9E-8E62-9F7925E46626

Q37735169-16C16811-1761-47A4-889E-2A490016B1FE

Q37735169-1B4DC4F3-6D06-4DF0-A4FD-D19CAE728AD4

Q37735169-1C946882-6000-4185-883E-B94E004CF1F7

Q37735169-1E7472DF-2838-405C-B37D-92B5958FE2D4

Q37735169-1F09F24D-9870-4468-B337-4A07045A85D8

Q37735169-1F9D4570-3032-43A2-947F-1239D9CE10C7

P304

Q37735169-573F4FED-735E-41B2-9116-DBB8E4C258D2

P31

Q37735169-B6F4DA27-4ED2-4E5E-8D27-BEFDFFCCDAC1

P356

Q37735169-50C1A0D1-B3A9-4FBC-AE52-F7467A5929C9

P407

Q37735169-EC038B52-96B7-40EA-9CB2-67BD8CB97DC6

P433

Q37735169-38558F10-6ECE-4A12-BC5E-70BE7076BC52

P478

Q37735169-AB064753-1E19-4546-B76C-C69BF1188A77

P577

Q37735169-0798D548-F881-4C4B-8670-3E43410354D1

P698

Q37735169-13DC5CAA-022B-4509-A752-1FCB400E9FB6

P921

Q37735169-EA58D5E3-F035-4557-8245-1B169AB6DE93

P356

13543784.2010.482926

P1433

Expert Opinion on Investigational Drugs

P1476

Investigational melatonin receptor agonists.

@en

P2093

Rüdiger Hardeland

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor

Circadian genes, rhythms and the biology of mood disorders

Pharmacological characterization of human recombinant melatonin mt(1) and MT(2) receptors

The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways

Chronobiotic effects of the melatonin agonist LY 156735 following a simulated 9h time shift: results of a placebo-controlled trial

Melatonin in mood disorders

Inverted rhythm of melatonin secretion in Smith-Magenis syndrome: from symptoms to treatment

Human circadian rhythms: physiological and therapeutic relevance of light and melatonin

Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategies

Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist

P304

747-764

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.2010.482926

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2010-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20408738

http://www.w3.org/2001/XMLSchema#string

P921